{"id":"W4286511961","doi":"10.1016/j.annonc.2022.05.065","title":"PS2-2 KEYNOTE-355 Asian subset: Pembrolizumab + chemotherapy vs placebo + chemotherapy for triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Chemotherapy; Oncology; Triple-negative breast cancer; Breast cancer; Internal medicine; Placebo; Cancer; Pathology; Immunotherapy; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007505578,0.0005255225,0.001244529,0.0001977233,0.0003206179,0.0008530595,0.000440338,0.0005595205,0.0132247],"category_scores_gemma":[0.0006849454,0.0002811516,0.001380721,0.0002044786,0.0003228358,0.0008024544,0.0003534924,0.002632359,0.001206573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006359018,"about_ca_system_score_gemma":0.001123361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001262975,"about_ca_topic_score_gemma":0.003575379,"domain_scores_codex":[0.9997614,0.0000778245,0.00001728348,0.00004724073,0.00002105437,0.00007515022],"domain_scores_gemma":[0.9997105,0.00006755571,0.00003977995,0.00002659884,0.00001667899,0.000138791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9203082,0.00534309,0.001692659,0.0005223936,0.00130547,0.00006737491,0.00006386891,0.0005733971,0.007938788,0.0003736759,0.005765746,0.05604541],"study_design_scores_gemma":[0.5430089,0.3666355,0.04167778,0.0003965865,0.00696821,0.0004883583,0.0004014998,0.002246336,0.008076692,0.002144621,0.02786611,0.00008940747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9772879,0.005244822,0.0005344976,0.001980108,0.00143209,0.0009720824,0.003203554,0.00009953017,0.009245335],"genre_scores_gemma":[0.983576,0.002924232,0.0008546722,0.001942145,0.0004531379,0.001013724,0.001911574,0.00002808634,0.007296476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0132247,"threshold_uncertainty_score":0.04424101,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04495780894443804,"score_gpt":0.3732214279464666,"score_spread":0.3282636190020286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}